Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of "Moderate Buy" by Analysts : vimarsana.com

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month price […]

Related Keywords

James Basta , Investment Management , Goldman Sachs Group , Nasdaq , Wolfe Research , Morgan Stanley , Norges Bank , Intellia Therapeutics Inc , Canaccord Genuity Group , Intellia Therapeutics , Get Free Report , Genuity Group , Partners Asset Management , State Street Corp , Street Corp , Get Free , Intellia Therapeutics Daily , Nasdaq Ntla , Ntla , Medical , Ratings , Consensus ,